Common isotopes include lutetium-177, actinium-225, gallium-68 (diagnostic), fluorine-18, and radium-223. The therapy combines isotopic radiance with molecular targeting-e.g., PSMA in prostate cancer ...

Private label continues to grow across key product categories in Europe, especially where consumers value affordability, quality, and ethical production. Leading segments include: ...

Estonia, France, Germany, the Netherlands, Portugal, Luxembourg and Spain on Thursday will launch a new marketing label for savings products that target European investments, France's finance ...

Officials including French Economy Minister Eric Lombard and his Spanish counterpart Carlos Cuerpo are scheduled to sign an agreement in Paris on Thursday for a label called “Finance Europe ...

PARIS (Reuters) -Estonia, France, Germany, the Netherlands, Portugal, Luxembourg and Spain on Thursday will launch a new marketing label for savings products that target European investments, France's ...

To qualify for the “Finance Europe” label, investment products must have at least 70% of assets in the European Economic Area, primarily in equities. They must also include an incentive for ...

Europe pharmacy automation systems market was valued at $1.32 billion in 2022 and will grow by 8.8% annually over 2022-2032, driven by the growing need to minimize medication errors and reduce ...

Alaska Airlines is making its first foray into the European travel market, announcing Tuesday it will launch new flights to and from Rome, Italy, beginning in May 2026.

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive initial results ...

The seven countries have agreed that the European savings product label will require at least 70% of assets to be invested in EU countries, with a focus on equity investments to help shore up ...

ALPHA-SOLAR is a long-term open-label trial in adults with HAE Type 1 or 2 designed to assess long-term safety and efficacy of navenibart. All 16 target enrollment participants from the Phase 1b/2 ...